The deubiquitinase OTULIN is an essential negative regulator of inflammation and autoimmunity

Rune Busk Damgaard, Jennifer A Walker, Paola Marco-Casanova, Neil V Morgan, Hannah L Titheradge, Paul R Elliott, Duncan McHale, Eamonn R Maher, Andrew N J McKenzie, David Komander

Research output: Contribution to journalArticlepeer-review

145 Citations (Scopus)
163 Downloads (Pure)

Abstract

Methionine-1 (M1)-linked ubiquitin chains regulate the activity of NF-κB, immune homeostasis, and responses to infection. The importance of negative regulators of M1-linked chains in vivo remains poorly understood. Here, we show that the M1-specific deubiquitinase OTULIN is essential for preventing TNF-associated systemic inflammation in humans and mice. A homozygous hypomorphic mutation in human OTULIN causes a potentially fatal autoinflammatory condition termed OTULIN-related autoinflammatory syndrome (ORAS). Four independent OTULIN mouse models reveal that OTULIN deficiency in immune cells results in cell-type-specific effects, ranging from over-production of inflammatory cytokines and autoimmunity due to accumulation of M1-linked polyubiquitin and spontaneous NF-κB activation in myeloid cells to downregulation of M1-polyubiquitin signaling by degradation of LUBAC in B and T cells. Remarkably, treatment with anti-TNF neutralizing antibodies ameliorates inflammation in ORAS patients and rescues mouse phenotypes. Hence, OTULIN is critical for restraining life-threatening spontaneous inflammation and maintaining immune homeostasis.

Original languageEnglish
Pages (from-to)1215–1230.e20
Number of pages36
JournalCell
Volume166
Issue number5
Early online date11 Aug 2016
DOIs
Publication statusPublished - 25 Aug 2016

Fingerprint

Dive into the research topics of 'The deubiquitinase OTULIN is an essential negative regulator of inflammation and autoimmunity'. Together they form a unique fingerprint.

Cite this